Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia: The "BENEFIT-KSA" Study

NCT07603284 is registered in ClinicalTrials.gov with DexCom, Inc. as lead sponsor.

NCT NCT07603284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07603284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi Arabia: The "BENEFIT-KSA" Study
Lead sponsor
DexCom, Inc.
Phase
Phase 4
Overall status
Active, not recruiting
Start date
November 24, 2025
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes on insulin